Before Josue Briceño even stepped into the batter’s box Thursday night, his performance had already taken on deeper meaning.

For NASCAR drivers Alex Bowman, Shane van Gisbergen and Ricky Stenhouse Jr., dogs are more than just pets, they're part of ...

Beam Therapeutics (NASDAQ:BEAM) gains FDA orphan drug status for BEAM-101 to treat sickle cell disease. Read more here.

underscoring the therapy’s promise and the urgent need for effective AATD solutions. Preliminary data from ongoing Phase 1/2 trials show BEAM-302 is well tolerated and achieves dose-dependent ...

has granted Regenerative Medicine Advanced Therapy (RMAT) designation to BEAM-302, a liver-targeting lipid-nanoparticle (LNP) formulation of a guide RNA and an mRNA encoding a base editor designed ...

With RMAT designation enabling closer and more frequent collaboration, we look forward to working with the FDA to accelerate the development of BEAM-302 and bring this potentially curative therapy to ...

This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization ...

Technology correspondent Rory Cellan-Jones has been having proton beam therapy for a tumour in his eye, at the Clatterbridge Cancer Centre on the Wirral, the only place in the UK to offer this ...

Currently, there are no curative treatments available, with the only approved therapy in the U.S. being intravenous AAT protein replacement, which does not halt lung function decline. Beam ...